Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06689696 · ClinicalTrials.gov registry record
24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
A clinical trial of Glaucoma and Ocular Hypertension, sponsored by Smartlens.
- Recruiting
- Registry status
- 125
- Enrollment target
- 3
- Study locations
NCT06689696 is a study of Glaucoma and Ocular Hypertension that is actively recruiting participants, run by Smartlens. The registered enrollment target is 125 participants, below the 909-participant average among 92 other Glaucoma trials with a reported enrollment target (86% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT06689696, a study of Glaucoma and Ocular Hypertension, is actively recruiting participants, sponsored by Smartlens.
- RECRUITING
- Registry status
- 125 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this clinical trial is to learn if a new contact lens device can record patterns in eye pressure for 24 hours in adults with glaucoma and in healthy participants. The main questions it aims to answer are: * Is the contact lens device able to detect patterns in eye pressure that happens naturally between nighttime and daytime? * Are the contact lens recording patterns similar when repeated one week later? * What eye problems do participants have when wearing contact lens for up to 24 hours? Researchers will compare if the recordings detected by the contact lens over 24 hours are similar to the patterns measured by an eye pressure measuring instrument used in a doctor's office. Participants will * Wear contact lens in one eye for up to 24 hours * Take recordings in that eye with smartphone camera every 15 minutes when awake * For those participants who are able to stay overnight at a hotel for the trial, researchers will measure the eye pressure in the other eye every 1 to 2 hours when awake with an eye pressure measuring instrument.
Conditions Studied
Interventions
- DEVICE miLens system
Study Locations (3)
California
- Nvision Clinical Reseacrh, LLC - Fullerton
- North Bay Eye Associates, Inc. - Petaluma
- Nvision Clinical Research, LLC - Torrance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2025-02-19 |
| Est. Completion | 2026-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06689696
The ClinicalTrials.gov registry entry for NCT06689696 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 909-participant average among 92 other Glaucoma trials with a reported enrollment target (86% lower). The listed sponsor is Smartlens, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which miLens system is the first listed.
NCT06689696 reports 3 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06689696 about?
NCT06689696 is a clinical study titled "24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring". The goal of this clinical trial is to learn if a new contact lens device can record patterns in eye pressure for 24 hours in adults with glaucoma and in healthy participants. The main questions it aims to answer are: * Is the contact lens device able to detect patterns in eye pressure that happens...
What is the current status of trial NCT06689696?
This trial is currently recruiting. The enrollment target is 125 participants. The study started on 2025-02-19. Estimated completion is 2026-02.
What conditions does trial NCT06689696 study?
This clinical trial studies the following conditions: Glaucoma, Ocular Hypertension, Glaucoma Open-Angle, Intraocular Pressure, Ocular Hypertension (OH).
What interventions are being tested in trial NCT06689696?
The interventions under investigation include: miLens system (DEVICE).
Who is sponsoring clinical trial NCT06689696?
This trial is sponsored by Smartlens, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06689696 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Functional and Structural Imaging for Glaucoma
RECRUITING
-
Topical Insulin for Glaucoma
RECRUITING · Phase 1
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
RECRUITING · Phase 2
-
Eye Pressure Lowering Surgery
RECRUITING
-
Tolerability of an Anesthesia-free Tonometer Tip
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.